ÂÜÀòÂÒÂ×

Gregory Johnson serves as the President and CEO of Cytophil, Inc. since 2016 and has been the Principal for Mergers, Acquisitions, and Analytics at Market Infomatrix since 2013, focusing on business and product expansion into new markets. Prior experience includes roles as General Manager at Torbot Group, where successful diversification strategies were implemented, and a position in Product/Business Integration at Smith & Nephew, overseeing a team of 36 direct reports. Additionally, Gregory held several executive roles in marketing and business development at companies such as Surgitek and Healthdyne Cardiovascular, along with serving as an adjunct professor at Concordia University. Gregory Johnson holds an MBA and a BS in Business Administration from Saint Mary's College of California.